A positive association of serum CCN5/WISP2 levels with the risk of developing gestational diabetes mellitus: a case–control study

Abstract Introduction CCN5/WISP2 is prominently manifest in adipose tissue and has been linked to the pathogenesis of obesity, diabetes, and insulin resistance. However, discrepancies exist in previous studies, and little is known about its association with gestational diabetes mellitus (GDM). The c...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed Farhan Hamdan Alshganbee, Fariba Nabatchian, Vida Farrokhi, Reza Fadaei, Nariman Moradi, Reza Afrisham
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Journal of Physiological Sciences
Subjects:
Online Access:https://doi.org/10.1186/s12576-023-00879-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849685196243206144
author Mohammed Farhan Hamdan Alshganbee
Fariba Nabatchian
Vida Farrokhi
Reza Fadaei
Nariman Moradi
Reza Afrisham
author_facet Mohammed Farhan Hamdan Alshganbee
Fariba Nabatchian
Vida Farrokhi
Reza Fadaei
Nariman Moradi
Reza Afrisham
author_sort Mohammed Farhan Hamdan Alshganbee
collection DOAJ
description Abstract Introduction CCN5/WISP2 is prominently manifest in adipose tissue and has been linked to the pathogenesis of obesity, diabetes, and insulin resistance. However, discrepancies exist in previous studies, and little is known about its association with gestational diabetes mellitus (GDM). The current investigation is designed to examine the correlation of WISP2 with risk factors in GDM patients in comparison to healthy pregnant women for the first time. Methods This case–control study measured serum levels of CCN5, TNF-α, IL-6, adiponectin, and fasting insulin using ELISA kits in 88 GDM patients and 88 pregnant women. Results The GDM group had remarkably higher serum levels of CCN5 (379.41 ± 83.078 ng/ml) compared to controls (212.02 ± 77.935 ng/ml). In a similar vein, it was observed that patients diagnosed with GDM exhibited elevated levels of pro-inflammatory cytokines such as IL-6 and TNF-α; while conversely, adiponectin levels were found to be significantly lower than those observed in the control group (P < 0.0001). In women with GDM, a positive and significant correlation was observed between CCN5 and BMI, FBG, insulin, HOMA-IR, as well as IL-6 and TNF-α levels. In the adjusted model, the risk of GDM was significantly increased with elevated serum CCN5 level. Conclusion Our research indicates a noteworthy and affirmative correlation between the levels of CCN5 in the serum and the risk of developing GDM, along with its associated risk factors such as BMI, insulin resistance index, FBG, and inflammatory cytokines (TNF-α and IL-6). These findings suggest that CCN5 could potentially play a role in the etiology of GDM.
format Article
id doaj-art-b96e41bf70f34d1f879cf1fae1288d5c
institution DOAJ
issn 1880-6562
language English
publishDate 2023-10-01
publisher Elsevier
record_format Article
series Journal of Physiological Sciences
spelling doaj-art-b96e41bf70f34d1f879cf1fae1288d5c2025-08-20T03:23:14ZengElsevierJournal of Physiological Sciences1880-65622023-10-017311710.1186/s12576-023-00879-zA positive association of serum CCN5/WISP2 levels with the risk of developing gestational diabetes mellitus: a case–control studyMohammed Farhan Hamdan Alshganbee0Fariba Nabatchian1Vida Farrokhi2Reza Fadaei3Nariman Moradi4Reza Afrisham5Department of Clinical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical SciencesDepartment of Clinical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical SciencesDepartment of Hematology, Faculty of Allied Medical Sciences, Tehran University of Medical SciencesSleep Disorders Research Center, Kermanshah University of Medical SciencesLiver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical SciencesDepartment of Clinical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical SciencesAbstract Introduction CCN5/WISP2 is prominently manifest in adipose tissue and has been linked to the pathogenesis of obesity, diabetes, and insulin resistance. However, discrepancies exist in previous studies, and little is known about its association with gestational diabetes mellitus (GDM). The current investigation is designed to examine the correlation of WISP2 with risk factors in GDM patients in comparison to healthy pregnant women for the first time. Methods This case–control study measured serum levels of CCN5, TNF-α, IL-6, adiponectin, and fasting insulin using ELISA kits in 88 GDM patients and 88 pregnant women. Results The GDM group had remarkably higher serum levels of CCN5 (379.41 ± 83.078 ng/ml) compared to controls (212.02 ± 77.935 ng/ml). In a similar vein, it was observed that patients diagnosed with GDM exhibited elevated levels of pro-inflammatory cytokines such as IL-6 and TNF-α; while conversely, adiponectin levels were found to be significantly lower than those observed in the control group (P < 0.0001). In women with GDM, a positive and significant correlation was observed between CCN5 and BMI, FBG, insulin, HOMA-IR, as well as IL-6 and TNF-α levels. In the adjusted model, the risk of GDM was significantly increased with elevated serum CCN5 level. Conclusion Our research indicates a noteworthy and affirmative correlation between the levels of CCN5 in the serum and the risk of developing GDM, along with its associated risk factors such as BMI, insulin resistance index, FBG, and inflammatory cytokines (TNF-α and IL-6). These findings suggest that CCN5 could potentially play a role in the etiology of GDM.https://doi.org/10.1186/s12576-023-00879-zCCN5/WISP2Gestational diabetes mellitusInflammationPregnancyWomen
spellingShingle Mohammed Farhan Hamdan Alshganbee
Fariba Nabatchian
Vida Farrokhi
Reza Fadaei
Nariman Moradi
Reza Afrisham
A positive association of serum CCN5/WISP2 levels with the risk of developing gestational diabetes mellitus: a case–control study
Journal of Physiological Sciences
CCN5/WISP2
Gestational diabetes mellitus
Inflammation
Pregnancy
Women
title A positive association of serum CCN5/WISP2 levels with the risk of developing gestational diabetes mellitus: a case–control study
title_full A positive association of serum CCN5/WISP2 levels with the risk of developing gestational diabetes mellitus: a case–control study
title_fullStr A positive association of serum CCN5/WISP2 levels with the risk of developing gestational diabetes mellitus: a case–control study
title_full_unstemmed A positive association of serum CCN5/WISP2 levels with the risk of developing gestational diabetes mellitus: a case–control study
title_short A positive association of serum CCN5/WISP2 levels with the risk of developing gestational diabetes mellitus: a case–control study
title_sort positive association of serum ccn5 wisp2 levels with the risk of developing gestational diabetes mellitus a case control study
topic CCN5/WISP2
Gestational diabetes mellitus
Inflammation
Pregnancy
Women
url https://doi.org/10.1186/s12576-023-00879-z
work_keys_str_mv AT mohammedfarhanhamdanalshganbee apositiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy
AT faribanabatchian apositiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy
AT vidafarrokhi apositiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy
AT rezafadaei apositiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy
AT narimanmoradi apositiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy
AT rezaafrisham apositiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy
AT mohammedfarhanhamdanalshganbee positiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy
AT faribanabatchian positiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy
AT vidafarrokhi positiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy
AT rezafadaei positiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy
AT narimanmoradi positiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy
AT rezaafrisham positiveassociationofserumccn5wisp2levelswiththeriskofdevelopinggestationaldiabetesmellitusacasecontrolstudy